Clinical Significance

Apolipoprotein A1 (APO-A1) is the primary protein associated with HDL cholesterol. Increased levels mostly indicate reduced risk of cardiovascular diseases. Estimation on APO-A1 is needed for monitoring the cardiac risk of subjects with a family history of CVD’s and also evaluating the effectiveness of lipid lowering therapy.

Price: 800